NEW YORK – Precision oncology firm Burning Rock Biotech this week presented data at two scientific conferences supporting two products it expects to be major growth drivers in coming years.
At the annual meeting of the Association for Molecular Pathology, held virtually, researchers from the company presented a study describing the validation of its automated next-generation sequencing library prep solution Magnis BR, which was launched last year.
Get the full story with
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.